ID: ALA5089175

Max Phase: Preclinical

Molecular Formula: C18H12BrN3OS

Molecular Weight: 398.29

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1c(-c2cccs2)nc2ccc(Br)cn12)c1ccccc1

Standard InChI:  InChI=1S/C18H12BrN3OS/c19-13-8-9-15-20-16(14-7-4-10-24-14)17(22(15)11-13)21-18(23)12-5-2-1-3-6-12/h1-11H,(H,21,23)

Standard InChI Key:  FJSUNQRXIVSANM-UHFFFAOYSA-N

Associated Targets(Human)

Gamma-aminobutyric acid receptor subunit alpha-4/beta-1/delta 32 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 398.29Molecular Weight (Monoisotopic): 396.9884AlogP: 5.08#Rotatable Bonds: 3
Polar Surface Area: 46.40Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.19CX LogP: 4.52CX LogD: 4.52
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.52Np Likeness Score: -2.26

References

1. Rostrup F, Falk-Petersen CB, Harpso E K, Buchleithner S, Conforti I, Jung S, Gloriam DE, Schirmeister T, Wellendorph P, Fro Lund B..  (2021)  Structural Determinants for the Mode of Action of Imidazopyridine DS2 at δ-Containing γ-Aminobutyric Acid Type A Receptors.,  64  (8.0): [PMID:33847501] [10.1021/acs.jmedchem.0c02163]

Source